[Effectiveness of prophylactic intracameral moxifloxacin to reduce endophthalmitis after cataract surgery]

Rev Med Chil. 2023 Mar;151(3):306-312. doi: 10.4067/s0034-98872023000300306.
[Article in Spanish]
No abstract available

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Antibiotic Prophylaxis
  • Cataract* / drug therapy
  • Endophthalmitis* / drug therapy
  • Endophthalmitis* / etiology
  • Endophthalmitis* / prevention & control
  • Fluoroquinolones / therapeutic use
  • Humans
  • Moxifloxacin
  • Postoperative Complications / prevention & control

Substances

  • Moxifloxacin
  • Anti-Bacterial Agents
  • Fluoroquinolones